KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Zoetis (ZTS) over the last 12 years, with Q4 2025 value amounting to $88.0 million.

  • Zoetis' Change in Accured Expenses rose 1282.05% to $88.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $85.0 million, marking a year-over-year decrease of 2543.86%. This contributed to the annual value of $85.0 million for FY2025, which is 2543.86% down from last year.
  • Zoetis' Change in Accured Expenses amounted to $88.0 million in Q4 2025, which was up 1282.05% from $101.0 million recorded in Q3 2025.
  • Zoetis' 5-year Change in Accured Expenses high stood at $165.0 million for Q4 2021, and its period low was -$222.0 million during Q1 2022.
  • Moreover, its 5-year median value for Change in Accured Expenses was $36.5 million (2024), whereas its average is $15.6 million.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first tumbled by 20833.33% in 2022, then soared by 82500.0% in 2024.
  • Over the past 5 years, Zoetis' Change in Accured Expenses (Quarter) stood at $165.0 million in 2021, then tumbled by 71.52% to $47.0 million in 2022, then surged by 100.0% to $94.0 million in 2023, then fell by 17.02% to $78.0 million in 2024, then increased by 12.82% to $88.0 million in 2025.
  • Its last three reported values are $88.0 million in Q4 2025, $101.0 million for Q3 2025, and $36.0 million during Q2 2025.